Aidence
Amsterdam
About Aidence
Aidence rallies 80+ data scientists, software engineers, medical, regulatory, and business professionals to provide intelligent software for the lung cancer pathway. Their first clinical application is Veye Lung Nodules, an AI solution for pulmonary nodule management on CTs. Veye is running in routine practice and lung cancer screening programmes across Europe.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.1M
- Funding stage: M&A
- Last round: Series A (Feb 2019)
- Website: aidence.com
- Phone: +310628541275
Industries & Categories
Artificial Intelligence (AI), Health Care, Health Diagnostics, Information Technology, Medical
Social Profiles
Canonical: https://fsome.com/organization/aidence-114667 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.